3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid has been researched along with dihydroxyphenylalanine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bristow, LJ; Hutson, PH; Thorn, L; Tricklebank, MD | 1 |
Bai, X; Carroll, FI; Downing-Park, J; Mascarella, SW; Patrick, RL; Patrick, SL; Walker, JM; Weiser, SD | 1 |
2 other study(ies) available for 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid and dihydroxyphenylalanine
Article | Year |
---|---|
Competitive NMDA receptor antagonists attenuate the behavioural and neurochemical effects of amphetamine in mice.
Topics: Amphetamine; Animals; Binding, Competitive; Corpus Striatum; Dihydroxyphenylalanine; Drug Interactions; Glycine; Male; Mice; Motor Activity; Neurons; Nucleus Accumbens; Pipecolic Acids; Piperazines; Receptors, N-Methyl-D-Aspartate | 1994 |
Stimulation of rat striatal tyrosine hydroxylase activity following intranigral administration of sigma receptor ligands.
Topics: Animals; Anticonvulsants; Aromatic Amino Acid Decarboxylase Inhibitors; Behavior, Animal; Chromatography, High Pressure Liquid; Corpus Striatum; Cyclazocine; Dihydroxyphenylalanine; Guanidines; Hydrazines; Male; Microinjections; Piperazines; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Receptors, sigma; Substantia Nigra; Tyrosine 3-Monooxygenase | 1995 |